Terazosin Capsule
Product Images NDC 72162-2182

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 72162-2182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622182)

Label for Terazosin Capsules USP 2 mg, containing 1000 capsules. The label includes storage instructions to keep at 20-25°C, advises dispensing in a light-resistant container, and warns to keep out of reach of children. It is relabeled by Bryant Ranch Prepack, Inc., and manufactured by Jubilant Cadista Pharmaceuticals Inc. A barcode and NDC 72162-2182-0 are also present.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

Chemical structure of Terazosin Hydrochloride, the active ingredient in Terazosin 2 mg oral capsules by Bryant Ranch Prepack.*

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

Two side-by-side graphs contrasting placebo and Terazosin effects over 3 months. The left graph shows mean change in total symptom score from baseline, indicating a greater decrease for Terazosin versus placebo. The right graph shows mean increase in peak flow rate from baseline (mL/sec), where Terazosin has a greater increase over placebo.*

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

A line graph showing mean change from baseline over 30 months. The vertical axis represents mean change values from 0 to -7, and the horizontal axis shows time in months from 0 to 30. Data points are connected by a line with markers, some highlighted by asterisks indicating significance.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

A line graph showing mean change from baseline over time in months, with data points plotted at various monthly intervals up to 30 months. The y-axis measures mean change in mL/sec, ranging from 0 to 4.5. Statistical significance is indicated by asterisks on multiple data points along the timeline.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.